Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2025, Vol. 39 ›› Issue (4): 26-30.doi: 10.6040/j.issn.1673-3770.0.2024.367

• Clinical Research • Previous Articles     Next Articles

Expression of EphB2 in nasopharyngeal carcinoma tissues and its correlation with clinicopathological characteristics

HUANG Qiao, REN Yi, HOU Tao, LIAO Xingwei, ZHU Zi’ang, ZHAN Xiaolin, LIU Ying, YIN Shihua   

  1. Department of Otorhinolaryngology & Head and Neck Surgery, the Second Affiliated Hospital of Guangxi Medical University, Nanning 530007, Guangxi, China
  • Online:2025-07-20 Published:2025-08-11

Abstract: Objective To investigate the expression and clinical significance of erythropoietin-producing human hepatocellular B2(EphB2)in tissues of patients with nasopharyngeal carcinoma(NPC). Methods 194 NPC patients were enrolled as the study group, and 80 patients with chronic nasopharyngeal mucosal inflammation were included as the control group. Immunohistochemistry(IHC)and Western blot were used to detect the EphB2 levels in tissues. Kaplan-Meier survival analysis was performed to evaluate the relationship between the expression of EphB2 and the prognosis of patients with NPC, and Cox regression analysis was used to identify independent risk factors for poor prognosis. Results Immunohistochemistry and protein blotting experiments showed that EphB2 protein level was highly expressed in NPC tissues compared with chronic inflammatory tissues of nasopharyngeal mucosa(t=157, P<0.001). The expression level of EphB2 in NPC tissues was correlated with clinical stage(χ2=24.573, P<0.001), depth of tumor invasion(χ2=6.280, P=0.012), presence of cervical lymph node metastasis(χ2=5.576, P=0.018), distant metastasis(χ2=7.588, P=0.006), EBV infection(χ2=6.754, P=0.009), and the presence of recurrence(χ2=9.182, P=0.002). Kaplan-Meier curves revealed that NPC patients with high EphB2 expression had a poor prognosis(χ2=7.010, P=0.008). Cox regression analysis further revealed that EphB2 was an independent risk factor affecting the prognosis of NPC. Conclusion EphB2 is an independent risk factor affecting the prognosis of NPC, which may be involved in the process of NPC occurrence and development, and it is expected to be a biological marker and potential therapeutic target for the early diagnosis and prognosis evaluation of NPC.

Key words: Nasopharyngeal carcinoma, Erythropoietin-producing human hepatocellular B2, Clinical pathology, Immunohistochemistry, Cox regression analysis

CLC Number: 

  • R739.6
[1] Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma[J]. Lancet, 2019, 394(10192): 64-80. doi:10.1016/S0140-6736(19)30956-0
[2] Wang FQ, Zhang HZ, Cheng ZG. EPHA2 promotes the invasion and migration of human tongue squamous cell carcinoma cal-27 cells by enhancing AKT/mTOR signaling pathway[J]. Biomed Res Int, 2021, 2021: 4219690. doi:10.1155/2021/4219690
[3] Husain A, Chiu YT, Sze KM, et al. Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma[J]. J Hepatol, 2022, 77(2): 383-396. doi:10.1016/j.jhep.2022.02.018
[4] Xiao T, Xiao YH, Wang WX, et al. Targeting EphA2 in cancer[J]. J Hematol Oncol, 2020, 13(1): 114. doi:10.1186/s13045-020-00944-9
[5] Pasquale EB. Eph receptors and ephrins in cancer progression[J]. Nat Rev Cancer, 2024, 24(1): 5-27. doi:10.1038/s41568-023-00634-x
[6] 黄巧, 尹时华. Eph/ephrin信号通路在耳鼻咽喉头颈疾病中的研究进展[J]. 中华耳科学杂志, 2024, 22(3): 504-508. doi:10.3969/j.issn.1672-2922.2024.03.031 HUANG Qiao, YIN Shihua. Progress of Research on Eph/ephrin signaling pathway in otolaryngological diseases[J]. Chinese Journal of Otology, 2024, 22(3): 504-508. doi:10.3969/j.issn.1672-2922.2024.03.031
[7] Wang FH, Zhang XT, Li YF, et al. The Chinese society of clinical oncology(CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021[J]. Cancer Commun(Lond), 2021, 41(8): 747-795. doi:10.1002/cac2.12193
[8] 王靖淞, 余灿, 张西, 等. KRT4在喉癌及癌旁正常黏膜组织中的表达及临床意义[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 12-17. doi: 10.6040/j.issn.1673-3770.0.2023.097 WANG Jingsong, YU Can, ZHANG Xi, et al. Expression and clinical significance of KRT4 in laryngeal carcinoma and adjacent normal mucosal tissues[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 12-17. doi: 10.6040/j.issn.1673-3770.0.2023.097
[9] Ling JJ, Chang AS, Zhao HY, et al. EPHB2 as a recurrence-related gene and a prognostic indicator in nasopharyngeal carcinoma: a bioinformatics screening and immunohistochemistry verification[J]. Histol Histopathol, 2022, 37(9): 889-897. doi:10.14670/HH-18-459
[10] Liu W, Yu CP, Li JF, et al. The roles of EphB2 in cancer[J]. Front Cell Dev Biol, 2022, 10: 788587. doi:10.3389/fcell.2022.788587
[11] Li Y, Zhang XF. Therapeutic effects of ephrin B receptor 2 inhibitors screened by molecular docking on cutaneous squamous cell carcinoma[J]. J Dermatolog Treat, 2022, 33(1): 373-379. doi:10.1080/09546634.2020.1756201
[12] 李艳. EphB2小分子抑制剂的筛选及其抗皮肤鳞状细胞癌的研究[D]. 兰州: 兰州大学, 2022
[13] Sato S, Vasaikar S, Eskaros A, et al. EPHB2 carried on small extracellular vesicles induces tumor angiogenesis via activation of ephrin reverse signaling[J]. JCI Insight, 2019, 4(23): e132447. doi:10.1172/jci.insight.132447
[14] Bhatia S, Hirsch K, Bukkapatnam S, et al. Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma[J]. Cancer Cell Int, 2017, 17: 41. doi:10.1186/s12935-017-0409-7
[15] Leung HW, Leung CON, Lau EY, et al. EPHB2 activates β-catenin to enhance cancer stem cell properties and drive sorafenib resistance in hepatocellular carcinoma[J]. Cancer Res, 2021, 81(12): 3229-3240. doi:10.1158/0008-5472.CAN-21-0184
[16] Venkitachalam S, Babu D, Ravillah D, et al. The ephrin B2 receptor tyrosine kinase is a regulator of proto-oncogene MYC and molecular programs central to barrett's neoplasia[J]. Gastroenterology, 2022, 163(5): 1228-1241. doi:10.1053/j.gastro.2022.07.045
[17] Hu YH, Xie QH, Zhao JM, et al. Interaction between the EPHB2 receptor and EFNB1 ligand drives gastric cancer invasion and metastasis via the Wnt/β-catenin/FAK pathway[J]. Int J Biol Macromol, 2024, 258(Pt 1): 128848. doi:10.1016/j.ijbiomac.2023.128848
[18] Zhou FQ, Wang BB, Wang H, et al. circMELK promotes glioblastoma multiforme cell tumorigenesis through the miR-593/EphB2 axis[J]. Mol Ther Nucleic Acids, 2021, 25: 25-36. doi:10.1016/j.omtn.2021.05.002
[19] 孙帅, 夏青, 李凡, 等. EphB2调控claudin-6对子宫内膜癌侵袭和转移的影响[J]. 临床与实验病理学杂志, 2023, 39(8): 944-952. doi:10.13315/j.cnki.cjcep.2023.08.011 SUN Shuai, XIA Qing, LI Fan, et al. EphB2 regulates the expression of claudin-6 to modulate endometrial cancer invasion and metastasis[J]. Chinese Journal of Clinical and Experimental Pathology, 2023, 39(8): 944-952. doi:10.13315/j.cnki.cjcep.2023.08.011
[1] QIU Qianhui, XIAO Xuping, YANG Qintai, YE Jing, DENG Zeyi, WANG Desheng, TAN Guolin, JIANG weihong,. Expert consensus on clinical management recommendations for carotid blowout syndrome secondary to NPC treatment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 1-18.
[2] WANG Siquan, ZHU Hongshen, ZHANG Xiaobin, ZHAO Zhouyang, MA Yue, YANG Yimei, HUANG Lijin. Analysis of factors associated with stroke and cranial nerve palsy after unilateral internal carotid artery embolization in patients with nasopharyngeal carcinoma after radiotherapy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 19-25.
[3] SUN Chunxiao, WANG Wenqing, YUE Tian, LIU Jisheng. Efficacy analysis of concurrent chemoradiotherapy with high and low cumulative cisplatin doses in the treatment of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 31-41.
[4] WANG Zaixing, TANG Zhiyuan, LI Dingbo, SHI Zhaohui, ZENG Xianhai, ZHANG Qiuhang. Treatment of internal carotid artery rupture caused by tumor recurrence and skull base osteonecrosis after radiotherapy for nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 49-58.
[5] SUN Fang, XIE Chubo, QIU Qianhui. Retrospective analysis of nutritional indexes and their impact on wound healing in patients with radiation-induced skull base osteoradionecrosis after treatment with nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 59-68.
[6] ZHU Ruikai, WU Jiarong, SUN Fang, XIE Chubo, QIU Qianhui. Computed tomography angiography-based assessment of internal carotid artery stenosis after radiotherapy for nasopharyngeal carcinoma and its associated factors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 77-84.
[7] QIN Debo, XUE Jiancheng, YANG Wenyue, HU Bing, CHEN Tao, YU Yanping, MENG Qingguo, SUN Huanji, MIAO Beiping, LU Yongtian. Changing the diagnosis and treatment of nasopharyngeal cancer: biomarkers and nasal endoscopic surgery synergise to advance early treatment development [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 85-92.
[8] WU Jiarong, QIU Qianhui. The role and significance of the skull base fascial tissue barrier in endoscopic resection of locally early recurrent nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 108-113.
[9] YANG Ming, LIU Xuexia, ZHANG Hua. Progress of m6A recognition protein IGF2BPs in head and neck cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 153-161.
[10] WU Min, LI Zhengyang, MENG Jie, YE Huiping. Molecular mechanisms of programmed cell death and its role in nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 152-157.
[11] ZHANG Maohua, WEI Rifu, ZHU Zhongshou, LIU Ping, GAO Shang, LI Huifeng. Effect of LncRNA PCAT-1 on the biological behaviour and chemosensitivity of nasopharyngeal carcinoma cells [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 68-76.
[12] LI Gui, YANG Yanli, LI Donghai, YAN Xiuying. Adult orbital xanthogranulomatous disease with clinicopathological analysis report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 80-85.
[13] LI Yaru, XU Zhenju, WANG Xiaojun, FU Tao, YUAN Yue, WU Ce. Rosai-Dorfman disease of the bilateral neck and nasopharynx: a case report and review of related cases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 108-114.
[14] ZHANG Jingyi, DONG Xiangyi, MU Yakui, SONG Xicheng. Research progress on pyroptosis in otorhinolaryngology diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 140-148.
[15] WANG Jingsong, YU Can, ZHANG Xi, DENG Qicheng, XIE Zhuoliang, ZHAO Rui, WEN Bei, LIU Hai. Expression and clinical significance of KRT4 in laryngeal carcinoma and adjacent normal mucosal tissues [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 12-17.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 89 -89 .
[2] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 90 -91 .
[3] LIU Da-yu,PAN Xin-liang,LEI Da-peng,ZHANG Li-qiang,LUAN Xin-yong . Surgical treatment for medial wall pyriform sinus cancer[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(1): 8 -11 .
[4] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(2): 188 -188 .
[5] LIU Yan,LIU Xin-yi,WANG Jin-ping,LI Da-jian . Measurement of the posterior tympanum and its clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 218 -221 .
[6] ZHAO Min,WANG Shou-sen,ZHEN Ze-nian,CHEN Xian-ming,WANG Mao-xin . Sphenoid sinus and trans-sphenoid surgery under nasal endoscopy and microscopy [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 244 -245 .
[7] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 252 -252 .
[8] LI Guang-hao . Selective low position and horizontal tracheotomy in larynx neoplasm[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(4): 325 -326 .
[9]

YU De-xian,ZHANG Wen-shan,PI Shi-jun,CAO Gui-xia,LI Yong-qiang,MA Qing,HUANG Jian

. Oil gauze of traditional Chinese medicine for nasal packing after functional endoscopic sinus surgery[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(4): 340 -342 .
[10] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(4): 381 -382 .